Graduate Student
Vanderbilt
Logan Vlach is a 3rd graduate student in Kim Rathmell’s lab at Vanderbilt University. He studies the histone methyltransferase, and tumor suppressor SETD2, which is frequently mutated or deleted in many tumor types, including clear cell renal cell carcinoma (ccRCC). His research interests include investigating the functions of Ki67, as well as how SETD2 loss affects RNA processing and splicing. Prior to pursuing his graduate degree, Logan Vlach worked for 3 years as a Senior Associate Research Scientist in translational development at Bristol-Myers Squibb (BMS) in Redwood City, CA. Prior to working BMS, Logan was a research technician in the lab of David Baltimore at Caltech, where he studied RNA processing and splicing. He did his undergraduate training at the University of California, Berkeley.